Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
Active, not recruiting · NCT04653740 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-09-17 | NCT04653740 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Oscar Lambret | 23 |
| Laboratoire PRISM - Michel SALZET | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Oscar Lambret | Lille | France | 1 |